| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 18, 2014Commitment to delivering innovative medical technologies creates most versatile cordless ultrasonic offering in the industry
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 18, 2014-- Covidien plc (NYSE:COV) today announced the expansion of its Sonicision™ Cordless Ultrasonic Dissection Device portfolio, following U.S. Food...
-
Sep 17, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 17, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a 13% increase in the quarterly dividend rate, from $0.32 per...
-
Sep 17, 2014Enhancements Give Physicians More Options for Treating Vertebral Compression Fractures
MEMPHIS, TN - September 17, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the launch of the KYPHON Express(TM) II Balloon Kyphoplasty Platform, which includes the next generation KYPHON ®...
-
Sep 17, 2014
MINNEAPOLIS - Sept. 17, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that its Board of Directors elected Elizabeth Nabel, M.D., president of Brigham & Women's Hospital and Brigham & Women's...
-
Sep 16, 2014New Data from the OpT2mise Efficacy Study to be Presented at EASD Annual Meeting
VIENNA - September 16, 2014 - Medtronic, Inc. (NYSE:MDT) today announced that new results from the OpT2mise trial are being presented at the European Association for the Study of Diabetes (EASD) 50th
-
Sep 16, 2014IN.PACT Global Study Reports Favorable Outcomes in Real-World Patient Population and Validates Key Findings from IN.PACT SFA Trial
WASHINGTON -- Sept. 16, 2014 -- Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) conference, the latest clinical and economic data on the IN.PACT Admiral...
-
Sep 15, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 15, 2014-- Covidien plc announced today the start of enrollment in two clinical trials designed to further underscore the safety and effectiveness of the...
-
Sep 15, 2014New External Heart Monitor and Remote Monitoring Center Help Patients Find Answers to Unexplained Cardiac Symptoms
MINNEAPOLIS - September 15, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the SEEQ(TM) Mobile Cardiac Telemetry (MCT) System, an external, wire-free, adhesive heart monitor...
-
Sep 13, 2014Cost Effectiveness of Self-Expanding Valve Driven by Improved Quality of Life Benefit and Superior One-Year Survival Rates over Surgical Aortic Valve Replacement
WASHINGTON, D.C., and MINNEAPOLIS - Sept. 13, 2014 - In the first-ever in-trial cost effectiveness analysis of transcatheter aortic valve replacement (TAVR) for patients at high risk for surgery,...
-
Sep 13, 2014TCT Late-Breaking First Report Reveals High Survival, Low Stroke Rates and Sustained Valve Performance
WASHINGTON, D.C. and MINNEAPOLIS - Sept. 13, 2014 - Medtronic, Inc. (NYSE: MDT) today announced new data showing that transcatheter aortic valve replacement (TAVR) with the CoreValve® System...
-
Sep 11, 2014Superior Deliverabilityi and Uncompromising Performance Distinguishes New Angioplasty Balloon
MINNEAPOLIS -- Sept. 11, 2014 -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the NC Euphora(TM) Noncompliant Balloon...
-
Sep 11, 2014
MINNEAPOLIS - Sept. 11, 2014 - Medtronic, Inc. (NYSE: MDT) was recognized as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability World Index...
-
Sep 10, 2014First Patients Successfully Treated in Study to Evaluate Next Generation Transcatheter Valve
MINNEAPOLIS - Sept. 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate the safety and effectiveness of the...
-
Sep 3, 2014Next-Generation TAVI System Offers Ability to Recapture and Reposition During Deployment
MINNEAPOLIS - Sept. 3, 2014 - Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Européene) Mark for the 23 mm CoreValve® Evolut(TM) R System for transcatheter aortic valve implantation...
-
Sep 2, 2014
MINNEAPOLIS - Sept 2, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Morgan Stanley Global Healthcare Conference,...
-
Aug 28, 2014Transaction expands Covidien’s market leading portfolio with next generation technology for treatment of varicose veins
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 28, 2014-- Covidien plc (NYSE: COV) today announced that it has acquired Sapheon, Inc., a privately-held developer of venous disease treatments. Financial...
-
Aug 28, 2014First U.S. Growth Guidance System Cleared to Treat Scoliosis with Children's Needs in Mind
MEMPHIS, TN - Aug. 28, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the 510(k) clearance and launch of the SHILLA(TM) Growth Guidance System. The system is designed for treatment of...
-
Aug 27, 2014NGC's Hospital Managed Services Business Adds to Medtronic's Growing Healthcare Services and Solutions Portfolio
TOLOCHENAZ - August 27, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of NGC Medical S.p.A. (NGC), a privately-held Italian company, in a transaction...
-
Aug 27, 2014Post-Market Clinical Trial Will Assess Superiority of the AdaptivCRT® Feature Compared to Standard CRT
MINNEAPOLIS - Aug. 27, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including patient...
-
Aug 26, 2014Sapiens' Deep Brain Stimulation Technologies Strengthen Medtronic's Neuromodulation Portfolio and Neuroscience Leadership Position
MINNEAPOLIS and EINDHOVEN - Aug. 26, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep...
-
Aug 26, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 26, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Aug 25, 2014AdaptivCRT® Algorithm Customizes Therapy for Heart Failure Patients and Improves Their Response Rates
MINNEAPOLIS - Aug. 25, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva®...
-
Aug 22, 2014Generates Opportunity to Leverage Existing Vascular Technologies and Customer Relationships to Drive Increased Market Penetration
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 22, 2014-- Covidien plc (NYSE:COV) today announced it has acquired Reverse Medical Corporation, a privately held medical device company focused on expanding...
-
Aug 21, 2014
MINNEAPOLIS - August 21, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.305 per share of the company's common stock. The quarterly dividend...
-
Aug 21, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 21, 2014-- Covidien plc (NYSE: COV) today announced that the U.S. Food and Drug Administration (FDA) has approved changes to the manufacturing process for...